Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 5, 2012, Pages 1712-1719

  Tosi, Flavia ^a   Negri, Carlo ^a   Perrone, Fabrizia ^a   Dorizzi, Romolo ^a   Castello, Roberto ^a   Bonora, Enzo ^a   Moghetti, Paolo ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; DEXAMETHASONE; ESTRADIOL; GLUCOSE; GONADORELIN AGONIST; GONADOTROPIN; HYDROCORTISONE; HYDROXYPROGESTERONE; INSULIN; PROGESTERONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERINSULINEMIA; HYPERINSULINISM; INSULIN BLOOD LEVEL; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STEROID METABOLISM; STEROID RELEASE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BUSERELIN; CROSS-SECTIONAL STUDIES; FEMALE; FERTILITY AGENTS, FEMALE; GONADAL STEROID HORMONES; HUMANS; HYPERINSULINISM; INSULIN; OVARY; POLYCYSTIC OVARY SYNDROME; RECEPTORS, LHRH;

EID: 84860725114     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2939     Document Type: Article

References (36)

1. Baptiste CG, Battista MC, Trottier A, Baillargeon JP 2010 Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 122:42-52
2. Lachelin GC, Judd HL, Swanson SC, Hauck ME, Parker DC, Yen SS 1982 Long term effects of nightly dexamethasone administration in women with polycystic ovarian disease. J Clin Endocrinol Metab 55:768-773
3. Rittmaster RS, Thompson DL 1990 Effects of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J Clin Endocrinol Metab 70:1096-1102
4. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327:157-162
5. Gilling-Smith C, Story H, Rogers V, Franks S 1997 Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 47:93-99
6. Rosencrantz MA, Coffler MS, Haggan A, Duke KB, Donohue MC, Shayya RF, Su HI, Chang RJ 2011 Clinical evidence for predominance of A-5 steroid production in women with polycystic ovary syndrome. J Clin Endocrinol Metab 96:1106-1113
7. Ehrmann DA, Barnes RB, Rosenfield RL 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353
8. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E, Muggeo M 2000 Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double blind, placebo-controlled 6-month trial, followed by open, long term clinical evaluation. J Clin Endocrinol Metab 85:139-146
9. Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, Polonsky KS 1997 Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2108-2116
10. Nestler JE, Jakubowicz DJ 1997 Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P45017a activity and serum androgens. J Clin Endocrinol Metab 82:4075-4079
11. Mehta RV, Patel KS, Coffler MS, Dahan MH, Yoo RY, Archer JS, Malcom PJ, Chang RJ 2005 Luteinizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment. J Clin Endocrinol Metab 90:2136-2141
12. Baillargeon JP, Carpentier A 2007 Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertil Steril 88:886-893
13. Nestler JE, Barlascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN, Blackard WG 1989 Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68:1027-1032
14. Prelevic GM, Wurzburger MI, Balint-Peric L, Nesic JS 1990 Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome. Lancet 336:900-903
15. Baillargeon JP 2007 Insulin action in polycystic ovary syndrome: in vivo and in vitro. In: Azziz R, ed. The polycystic ovary syndrome: current concepts on pathogenesis and clinical care. New York: Springer; 43-68
16. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F 1998 Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using in ositolglycan mediatorsasthe signal transduction system. J Clin Endocrinol Metab 83:2001-2005
17. Nelson-Degrave VL, Wickenheisser JK, Hendricks KL, Asano T, Fujishiro M, Legro RS, Kimball SR, Strauss 3rd JF, McAllister JM 2005 Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in thecal cells contributed to excessive androgen production in polycystic ovary syndrome. Mol Endocrinol 19:379-390
18. Willis D, Mason H, Gilling-Smith C, Franks S 1996 Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81:302-309
19. Sekar N, Garmey JC, Veldhuis JD 2000 Mechanisms underlying the steroidogenic synergy of insulin and luteinizing hormone in porcine granulosa cells: joint amplification of pivotal sterol-regulatory genes encoding the low-density lipoprotein (LDL), receptor steroidogenic acute regulatory (StAR) protein and cytochrome P450 side-chain cleavage (P450scc) enzyme. Mol Cell Endocrinol 159:25-35
20. Dunaif A, Graf M 1989 Insulin administration alters gonadalsteroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. J Clin Invest 83:23-29
21. Patel K, Coffler MS, Dahan MH, Yoo RY, Lawson MA, Malcom PJ, Chang RJ 2003 Increased luteinizing hormone secretion in women with polycystic ovary syndrome is unaltered by prolonged insulin infusion. J Clin Endocrinol Metab 88:5456-5461
22. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 377-384
23. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47
24. Kumar A, Woods KS, Bartolucci AA, Azziz R 2005 Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 62:644-649
25. Tosi F, Negri C, Brun E, Castello R, Faccini G, Bonora E, Muggeo M, Toscano V, Moghetti P 2011 Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women. Eur J Endocrinol 164:197-203
26. Moghetti P, Castello R, Negri C, Tosi F, Spiazzi GG, Brun E, Balducci R, Toscano V, Muggeo M 1996 Insulin infusion amplifies 17α-hydroxysteroids intermediates response to ACTH in hyperandrogenic women: apparent relative impairment of 17, 20-lyase activity. J Clin Endocrinol Metab 81:881-886
27. De Fronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
28. Schmidt NA, Borburgh HJ, Penders TJ, Weykamp CW 1985 Steroid profiling-an update. Clin Chem 31:637-639
29. Munir I, Yen HW, Geller DH, Torbati D, Bierden RM, Weitsman SR, Agarwal SK, Magoffin DA 2004 Insulin augmentation of 17α-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells. Endocrinology 145:175-183
30. Stuart CA, Prince MJ, Peters EJ, Meyer 3rd WJ 1987 Hyperinsulinemia and hyperandrogenemia: in vivo androgen response to insulin infusion. Obstet Gynecol 69:921-925
31. Stuart CA, Nagamani MD 1990 Insulin infusion acutely augments ovarian androgen production in normal women. Fertil Steril 54:788-792
32. Nestler JE, Clore JN, Strauss 3rd JF, Blackard WG 1987 The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepi and rosterone sulphate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance and acanthosis nigricans. J Clin Endocrinol Metab 64:180-184
33. Diamond MP, Grainger DA, Laudano AJ, Starick-Zych K, De-Fronzo RA 1991 Effect of acute physiological elevation of insulin on circulating androgen levels in nonobese women. J Clin Endocrinol Metab 72:883-887
34. Micic D, Popovich V, Nesovic M, Sumarac M, Dragasevic M, Kendereski A, Markovic D, Djordjevic P, Manojlovic D, Micic J 1988 Androgens levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease. J Steroid Biochem 31:995-999
35. Lawson MA, Jain S, Sun S, Patel K, Malcom PJ, Chang RJ 2008 Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women. J Clin Endocrinol Metab 93:2089-2096
36. Moghetti P, Tosi F, Castello R, Magnani CM, Negri C, Brun E, Furlani L, Caputo M, Muggeo M 1996 The insulin resistance in women with hyperandrogenism is partially reversed by anti-androgen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 81:952-960